BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 32521719)

  • 21. Translocator Protein Ligand PIGA1138 Reduces Disease Symptoms and Severity in Experimental Autoimmune Encephalomyelitis Model of Primary Progressive Multiple Sclerosis.
    Tremolanti C; Cavallini C; Meyer L; Klein C; Da Pozzo E; Costa B; Germelli L; Taliani S; Patte-Mensah C; Mensah-Nyagan AG
    Mol Neurobiol; 2022 Mar; 59(3):1744-1765. PubMed ID: 35018577
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PIF* promotes brain re-myelination locally while regulating systemic inflammation- clinically relevant multiple sclerosis M.smegmatis model.
    Migliara G; Mueller M; Piermattei A; Brodie C; Paidas MJ; Barnea ER; Ria F
    Oncotarget; 2017 Mar; 8(13):21834-21851. PubMed ID: 28423529
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cerebrospinal fluid, brain, and spinal cord levels of L-aspartate signal excitatory neurotransmission abnormalities in multiple sclerosis patients and experimental autoimmune encephalomyelitis mouse model.
    Errico F; Gilio L; Mancini A; Nuzzo T; Bassi MS; Bellingacci L; Buttari F; Dolcetti E; Bruno A; Galifi G; Furlan R; Finardi A; Di Maio A; Di Filippo M; Centonze D; Usiello A
    J Neurochem; 2023 Aug; 166(3):534-546. PubMed ID: 37332201
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The nod-like receptor, Nlrp12, plays an anti-inflammatory role in experimental autoimmune encephalomyelitis.
    Gharagozloo M; Mahvelati TM; Imbeault E; Gris P; Zerif E; Bobbala D; Ilangumaran S; Amrani A; Gris D
    J Neuroinflammation; 2015 Oct; 12():198. PubMed ID: 26521018
    [TBL] [Abstract][Full Text] [Related]  

  • 25. N-Methyl-D-aspartate (NMDA) receptor involvement in central nervous system prostaglandin production during the relapse phase of chronic relapsing experimental autoimmune encephalomyelitis (CR EAE).
    Bolton C; Wood EG; Ayoub SS
    Fundam Clin Pharmacol; 2013 Oct; 27(5):535-43. PubMed ID: 22742874
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Silencing of the RNA-binding protein HuR attenuates hyperalgesia and motor disability in experimental autoimmune encephalomyelitis.
    Sanna MD; Quattrone A; Galeotti N
    Neuropharmacology; 2017 Sep; 123():116-125. PubMed ID: 28599923
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Central nervous system expression and PET imaging of the translocator protein in relapsing-remitting experimental autoimmune encephalomyelitis.
    Mattner F; Staykova M; Berghofer P; Wong HJ; Fordham S; Callaghan P; Jackson T; Pham T; Gregoire MC; Zahra D; Rahardjo G; Linares D; Katsifis A
    J Nucl Med; 2013 Feb; 54(2):291-8. PubMed ID: 23321458
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protective Effects on Central Nervous System by Acidic Polysaccharide of Panax ginseng in Relapse-Remitting Experimental Autoimmune Encephalomyelitis-Induced SJL/J Mice.
    Bing SJ; Ha D; Hwang I; Park E; Ahn G; Song JY; Jee Y
    Am J Chin Med; 2016; 44(6):1099-1110. PubMed ID: 27627913
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pien Tze Huang Alleviates Relapsing-Remitting Experimental Autoimmune Encephalomyelitis Mice by Regulating Th1 and Th17 Cells.
    Qiu X; Guo Q; Liu X; Luo H; Fan D; Deng Y; Cui H; Lu C; Zhang G; He X; Lu A
    Front Pharmacol; 2018; 9():1237. PubMed ID: 30429789
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relation between pro-inflammatory cytokines and acetylcholine levels in relapsing-remitting multiple sclerosis patients.
    Reale M; de Angelis F; di Nicola M; Capello E; di Ioia M; Luca Gd; Lugaresi A; Tata AM
    Int J Mol Sci; 2012 Oct; 13(10):12656-64. PubMed ID: 23202919
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The contribution of astrocytes to the neuroinflammatory response in multiple sclerosis and experimental autoimmune encephalomyelitis.
    Brambilla R
    Acta Neuropathol; 2019 May; 137(5):757-783. PubMed ID: 30847559
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulated Extracellular Choline Acetyltransferase Activity- The Plausible Missing Link of the Distant Action of Acetylcholine in the Cholinergic Anti-Inflammatory Pathway.
    Vijayaraghavan S; Karami A; Aeinehband S; Behbahani H; Grandien A; Nilsson B; Ekdahl KN; Lindblom RP; Piehl F; Darreh-Shori T
    PLoS One; 2013; 8(6):e65936. PubMed ID: 23840379
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Opioid growth factor and low-dose naltrexone impair central nervous system infiltration by CD4 + T lymphocytes in established experimental autoimmune encephalomyelitis, a model of multiple sclerosis.
    Hammer LA; Waldner H; Zagon IS; McLaughlin PJ
    Exp Biol Med (Maywood); 2016 Jan; 241(1):71-8. PubMed ID: 26202376
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The cholinergic anti-inflammatory system limits T cell infiltration into the neurodegenerative CNS, but cannot counteract complex CNS inflammation.
    Nicolussi EM; Huck S; Lassmann H; Bradl M
    Neurobiol Dis; 2009 Jul; 35(1):24-31. PubMed ID: 19344760
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Delineating the Role of Toll-Like Receptors in the Neuro-inflammation Model EAE.
    Fallarino F; Gargaro M; Mondanell G; Downer EJ; Hossain MJ; Gran B
    Methods Mol Biol; 2016; 1390():383-411. PubMed ID: 26803641
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential expression of inflammatory cytokines parallels progression of central nervous system pathology in two clinically distinct models of multiple sclerosis.
    Begolka WS; Vanderlugt CL; Rahbe SM; Miller SD
    J Immunol; 1998 Oct; 161(8):4437-46. PubMed ID: 9780223
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Central nervous system gene therapy with interleukin-4 inhibits progression of ongoing relapsing-remitting autoimmune encephalomyelitis in Biozzi AB/H mice.
    Furlan R; Poliani PL; Marconi PC; Bergami A; Ruffini F; Adorini L; Glorioso JC; Comi G; Martino G
    Gene Ther; 2001 Jan; 8(1):13-9. PubMed ID: 11402297
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pentraxin-3 is upregulated in the central nervous system during MS and EAE, but does not modulate experimental neurological disease.
    Ummenthum K; Peferoen LA; Finardi A; Baker D; Pryce G; Mantovani A; Bsibsi M; Bottazzi B; Peferoen-Baert R; van der Valk P; Garlanda C; Kipp M; Furlan R; van Noort JM; Amor S
    Eur J Immunol; 2016 Mar; 46(3):701-11. PubMed ID: 26576501
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Experimental models of relapsing-remitting multiple sclerosis: current concepts and perspective.
    Skundric DS
    Curr Neurovasc Res; 2005 Oct; 2(4):349-62. PubMed ID: 16181126
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Seropositive Neuromyelitis Optica in a Case of Undiagnosed Ankylosing Spondylitis: A Neuro-Rheumatological Conundrum.
    Ghosh Md R; Roy D; León-Ruiz M; Das S; Dubey S; Benito-León J
    Qatar Med J; 2022; 2022(3):29. PubMed ID: 35864917
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.